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Abstract
Background: Lack of validity in osteoarthritis pain models and assessment methods is suspected. Our goal was to
1) assess the repeatability and reproducibility of measurement and the influence of environment, and
acclimatization, to different pain assessment outcomes in normal rats, and 2) test the concurrent validity of the
most reliable methods in relation to the expression of different spinal neuropeptides in a chemical model of
osteoarthritic pain.
Methods: Repeatability and inter-rater reliability of reflexive nociceptive mechanical thresholds, spontaneous static
weight-bearing, treadmill, rotarod, and operant place escape/avoidance paradigm (PEAP) were assessed by the intraclass
correlation coefficient (ICC). The most reliable acclimatization protocol was determined by comparing coefficients of
variation. In a pilot comparative study, the sensitivity and responsiveness to treatment of the most reliable methods were
tested in the monosodium iodoacetate (MIA) model over 21 days. Two MIA (2 mg) groups (including one lidocaine
treatment group) and one sham group (0.9 % saline) received an intra-articular (50 μL) injection.
Results: No effect of environment (observer, inverted circadian cycle, or exercise) was observed; all tested methods
except mechanical sensitivity (ICC <0.3), offered good repeatability (ICC ≥0.7). The most reliable acclimatization protocol
included five assessments over two weeks. MIA-related osteoarthritic change in pain was demonstrated with static
weight-bearing, punctate tactile allodynia evaluation, treadmill exercise and operant PEAP, the latter being the most
responsive to analgesic intra-articular lidocaine. Substance P and calcitonin gene-related peptide were higher in MIA
groups compared to naive (adjusted P (adj-P) = 0.016) or sham-treated (adj-P = 0.029) rats. Repeated post-MIA lidocaine
injection resulted in 34 times lower downregulation for spinal substance P compared to MIA alone (adj-P = 0.029),
with a concomitant increase of 17 % in time spent on the PEAP dark side (indicative of increased comfort).
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Conclusion: This study of normal rats and rats with pain established the most reliable and sensitive pain
assessment methods and an optimized acclimatization protocol. Operant PEAP testing was more responsive to
lidocaine analgesia than other tests used, while neuropeptide spinal concentration is an objective quantification
method attractive to support and validate different centralized pain functional assessment methods.
Keywords: Animal preclinical model, Osteoarthritis, Monosodium iodoacetate, Methods, Validation,
Acclimatization, Pain metrology, Neuropeptide
Background
Osteoarthritis (OA), the most common of all arthropa-
thies in our aging population, is a leading cause of dis-
ability and represents a large (and growing) worldwide
socio-economic cost [1]. It affects approximately 30 mil-
lion adults in the USA [2], and this number is expected
to double by 2020 [3], with longer life expectancy and
the increasing incidence of obesity, two major risk fac-
tors for the disease. Despite critical importance in drug
development, translation of OA therapies focusing either
on structure (disease-modifying OA drugs) or pain
(symptom-modifying OA drugs) from the bench to bed-
side has slowed [1, 4, 5]. Differences between preclinical
OA models and the disease evaluated in clinical trials
contribute to this failure. Rising criticism is noted over
the classic translational research, which has failed to pre-
dict the efficacy of chronic pain treatments [6–9]. Most
critics have targeted the poor validity and clinical rele-
vance of experimental pain models using laboratory ani-
mals [10, 11]. It has also been hypothesized that current
animal models are too reliant on evoked (reflexive) with-
drawal responses and that development of meaningful
assessment tools allowing, for instance, the measure-
ment of continuous spontaneous pain, might help to
translate experimental data to clinical practice [6, 12].
Naturally occurring OA models are recognized to
present pathophysiological changes closest to clinical OA,
particularly in large animals [13], but also entail experi-
mental disadvantages (long period to onset, and variability
of disease development). In contrast, chemical models
cause the most rapidly progressing OA, requiring less
invasive procedures and enabling standardization (with
increased sample homogeneity). The monosodium iodoa-
cetate (MIA) chemical OA model as described 25 years
ago induces cartilage degeneration by disruption of chon-
drocyte metabolism (i.e., breaking down the cellular aer-
obic glycolysis). In rats, the MIA model is well-established
and resembles the histological and pain-related character-
istics of human degenerative OA [14–29]. Owing to the
extensive description of the pain response in rats, the
MIA OA model was proposed as a standard OA model
for pain assessment [23, 30].
The quality of pain assessment methodologies is a
cornerstone of preclinical studies targeting new analgesics
[7, 10–12, 16, 31, 32]. Three different categories of pain
expression can be evaluated in rats: reflexive measures,
spontaneous measures, and operant responses [8, 31].
First, reflexive measures using stimulus-evoked responses
are commonly used in rats to assess potential hyperalgesia
and allodynia, recognized as a clinical expression of the
neuropathic pain (nociceptive sensitization) component
[8, 33–35]. These measures are generated by exposure to
thermal, mechanical, or electrical stimulus, involving
mainly spinal-level pain processing, and are also increas-
ingly present in human quantitative sensory testing
characterization of pain [36–38]. Second, spontaneous
measures can be useful to quantify pain and/or wellbeing
[8]. For example, kinetic (static or dynamic weight distri-
bution) [14] or kinematic [39] (ambulation evaluation or
characterization) measurement, and spontaneous activity
[24] can indirectly assess quality of life in OA models.
Pain-induced behaviors (scratching/licking/biting, hypo-
phagia, vocalization, etc.) should also be considered in this
category [37]. Finally, operant responses have been more
recently introduced to characterize pain in animal models
[8, 34, 40–44]. Operant testing is opposite to reflexive re-
sponse testing as it allows the quantification of behavioral
responses at higher levels of the brain, reproducing mul-
tiple dimensions of pain, including affective and cognitive
changes and not only sensory-discriminative perception
[42, 43, 45, 46]. This type of measure allows the observer
to evaluate the aversive component of pain as operant
tests give the animal an opportunity to avoid the painful
condition [33, 40–43, 47–49].
In patients OA of the knee joint, pain is a combination
of inflammatory, immune and neurogenic components
participating in the hypersensitivity syndrome. Central
sensitization mechanisms [50] include various biochemical
processes such as increased spinal release of neurotrans-
mitters and neuromodulators, and increased excitability of
postsynaptic neurons. In an OA [51] and arthritis [52] rat
model, higher levels of neuropeptides, such as substance P
(SP) and calcitonin gene-related peptide (CGRP) have
been found in the spinal cord. Thus, nervous system
modulation seems to play a critical role in the develop-
ment of the disease [53]. The contribution of these spinal
neuromediators to neurogenic inflammation-mediated
chronic pain in OA, and concomitant changes in
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functional pain assessment methods has not been fully
established.
With such a variety of methods for pain and analgesic
response assessment, it is difficult to opt for the method(s)
most adapted to specific conditions. The current study
undertook to establish, the reliability of a panel of pain as-
sessment methods (including reflexive, spontaneous, and
operant testing) in normal rats, and the influence of envir-
onmental conditions, including acclimatization and ex-
perimental conditions of manipulation (observer, inverted
circadian cycle, and exercise). The most reliable methods
were then used to characterize OA pain in the well-
established chemical MIA model in rats, while conducting
concurrent validation of pain assessment methods in rela-
tion to the expression of different spinal neuropeptides




During the study, care and use of animals were subject
to and approved by the Comité d’Éthique de l’Utilisation
des Animaux of Université de Montréal (#Rech-1495)
and conducted in accordance with principles outlined in
the current Guide to the Care and Use of Experimental
Animals published by the Canadian Council on Animal
Care and the Guide for the Care and Use of Laboratory
Animals published by the US National Institutes of
Health.
Animals
The present study was conducted on female (n = 63; ex-
cluding spares) Sprague-Dawley rats (Charles River La-
boratories, Saint-Constant, QC, Canada) ranging from
225–300 g in weight at the beginning of experiment.
The animals were housed under regular laboratory con-
ditions and maintained under a light-dark cycle with
food and water provided ad libitum. Body weight was
obtained weekly. At the end of each experiment, the ani-
mals were returned to their housing colony.
Phase 1: reliability of pain assessment methods in normal
rats
Experimental design
Phase 1 included a total of 39 normal rats distributed
into 8 groups. First, the repeatability of measurements
was tested for the influence of environment, including
observer, inverted circadian cycle (activity during the
day), and exercise (two groups of five animals in cross-
over). Additionally, repeatability over an extended period
was tested again for static weight-bearing (SWB; one
group of four animals also tested for exercise effect), and
for tactile sensitivity and place escape/avoidance para-
digm (PEAP) operant test (one group of five animals).
Second, using the most reliable methods only, the influ-
ence of four acclimatization protocols (four groups of five
animals) was tested to determine the most effective ap-
proach to obtain predictable data with low variability. Dif-
ferent pain assessment methods were selected to include
reflexive, spontaneous behavior and operant measures.
Influence of environment
First, rats (n = 10) were randomly distributed into two
groups of five. Animals were acclimated to the test ap-
paratus on two occasions at day -3 and -1 before starting
the experimentation. In a crossover design, the animals
were subsequently assessed for three repeated days dur-
ing light (1000–1400 h) and dark (2000–2400 h) cycles
to test the influence of inverted circadian cycles. Both
cycles were separated by a 3-day washout period without
assessment. Dark cycle evaluations were performed
under low-intensity red light. Animals were tested on
each of six assessment days by two observers, with the
following methods in this order of evaluation: mechan-
ical and tactile sensitivity, SWB, treadmill exercise,
mechanical and tactile sensitivity, SWB, PEAP operant
test (without nociceptive stimulation) and rotarod ac-
ceptance. The mechanical and tactile nociceptive thresh-
olds and SWB evaluation were performed before and
after the treadmill exercise to verify the influence of ex-
ercise on these three pain assessment methods. Finally,
PEAP and rotarod were performed at the end of the
evaluation schedule to ensure respectively, that the
length of the test, and possible falling from the test de-
vice would not impair the other outcomes. To test inter-
rater reliability, two female observers were selected for
their different levels of experience in laboratory animals
(one intermediate, one with advanced expertise).
Second, in complementary studies about test repeat-
ability (after acclimatization on two occasions, at day -3
and -1), SWB was specifically retested over 15 days with
two SWB assessments separated by a treadmill session
(then testing again the potential effect of exercise on
SWB) in a group of four rats. This evaluation was done
daily, from days 1 to 5, then on days 8 and 15.
Finally, the repeatability of measurements of tactile
sensitivity and PEAP (with nociceptive stimulation) was
tested in a group of five rats over 25 days. These evalua-
tions were done daily, from days 1 to 15, and repeated
on days 18 and 25.
Influence of acclimatization protocols
In order to determine the most efficient acclimatization
protocol associated with the most repeatable data (previ-
ously obtained), the next experiment was conducted in a
total of 20 animals (four groups of 5 animals). Briefly,
over 2 weeks, different acclimatization protocols were
tested and included 8 (days -14, -13, -12, -11, -10, -8, -6,
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and -1), 6 (days -14, -8, -7, -6, -5, and -1), 5 (days -14,
-7, -5, -3, and -1) or 4 (days -14, -8, -6, and -1) days of
evaluation. The order of assessment was SWB, tactile
and mechanical sensitivity, PEAP with nociceptive
stimulation, and treadmill. The schedule of pain evalu-
ation methods was determined to obtain nociceptive
threshold values before placing the animal on the oper-
ant testing device where many paw stimulations were
elicited (see subsequent description).
Pain assessment methods
Mechanical sensitivity Mechanical sensitivity was
assessed by measuring the paw withdrawal threshold
(PWT) to an increasing pressure stimulus placed on
the dorsal surface of the hind paw using an algori-
meter (Randall Selitto test Paw Pressure Meter®, IITC
Life Science Inc., Woodland Hills, CA, USA), employing a
wedge-shaped probe (1.75 mm2 of surface) and a cutoff
value set at 250 g. The animals were placed in a sling ap-
paratus (Lomir Biomedical Inc., Notre-Dame-de-l’Île-Per-
rot, QC, Canada). The probe was applied once on the
dorsal surface at a steadily increasing pressure. The PWT
was determined when the animal removed the paw from
the apparatus, and the required pressure was recorded.
Withdrawal thresholds were measured on the right and
left hind paws. The data were expressed as PWT in grams.
Tactile sensitivity First, the animal was placed inside an
elevated metal grid cage to allow just enough space for
the rat to move while being restricted. After the rat ex-
ploration session during the first 2 minutes, tactile sensi-
tivity was assessed using an Electronic von Frey
Anesthesiometer® (IITC Life Science Inc., Woodland
Hills, CA, USA) applied to the plantar surface of the
hind paws and by measuring the PWT to von Frey as-
cending mechanical stimuli. Gradually increasing pres-
sure was applied with a mechanical von Frey
polypropylene probe (0.7 mm2, Rigid Tip®, IITC Life Sci-
ence Inc., Woodland Hills, CA, USA) fitted to a hand-
held force transducer. The rigid tip was placed
perpendicularly into the mid-plantar surface of the paw.
The stimulus was continued until the hind paw was
withdrawn or elevated such that the force leveled off.
Actions such as vocalization, agitation, jumping, and
avoidance were considered indicative of the PWT. Vol-
untary movements associated with locomotion were not
considered to be a withdrawal response. The peak of
force in grams was recorded with a cutoff value at 100 g.
For each animal, triplicates of each hind paw were taken
with a 60-s interval between each stimulus.
Static weight bearing The weight distribution through
the right and left knee was assessed using an Incapaci-
tance Meter® (IITC Life Science Inc., Woodland Hills,
CA, USA) to measure SWB distribution in the two hind
limbs. The force exerted by each hind limb was mea-
sured and analyzed in grams, but reported in percentage
of total body weight (%BW) to normalize the data. Rats
were allowed to acclimate to the testing apparatus and
when stationary, readings were taken over a 3-s period.
Triplicates were taken simultaneously for each limb at
each time point.
Treadmill exercise All rats underwent forced training
over a 20-minute period at constant treadmill speed
(11 m/minute) (IITC Life Science Inc., Woodland Hills,
CA, USA). To force the animal to exercise on the tread-
mill belt, each lane was equipped with an independent
shocker grid. The intensity of the shocker grid was kept
at the minimum required to keep the animal on the ex-
ercise belt. The treadmill number of total crossings
(TNTC) was recorded over the whole period, but also
reported in blocks of 5 minutes, to potentially detect a
within-time change in activity. A total crossing was con-
sidered completed when the animal crossed the entire
length of the lane. The TNTC was used as an indicator
of exercise and/or performance. When the rats were
running continuously on the belt, they were exposed to
maximal intensity exercise, as they were not pausing,
causing them to cross the entire length of the motorized
lane.
Operant testing The PEAP was used as operant testing
apparatus [33, 40, 49]. Rats were placed into test cage
apparatus that was painted half white and half black.
Neither side was illuminated with additional light. With
the cage on an elevated metal grid, the observer, located
below, determined the preferential location of the rat.
The 20-minute observation period began after 2 minutes
of acclimatization/exploration to the test environment
on each occasion.
Operant testing without nociceptive stimulation The
percentage of time spent on the black or white side of
the test apparatus was calculated from observation of
the preferential location every 15 s.
Operant testing with nociceptive stimulation If the
rat was on the black side of the test apparatus, the plan-
tar surface of the right (ipsilateral to possible MIA intra-
articular injection) hind paw (RHP) was stimulated with
a thin wire (60 g) every 15 s, to prompt withdrawal of
the limb. When the rat was on the white side of the
cage, a similar mechanical stimulation was applied, but
to the plantar surface of the left (contralateral) hind paw
(LHP). The percentage of time in the black and white
side of the test apparatus was calculated from observa-
tion of the preferential location every 15 s. The
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calculations were sequenced by successive blocks (n = 4)
of 5-minute periods. Moreover, the total number of
crossings from the white to the dark side was noted to
detect any decrease in activity. If a rat remained in the
crossing tunnel, it would be stimulated to advance and
complete its crossing.
Rotarod Using a Rotamex 4/8® (Columbus Instruments
Inc., Columbus, OH, USA) with a previously published
protocol [29], the rats were exposed to an acceleration
speed of 5 to 16 rpm, over 60 s, before being maintained
at this speed, while the time before falling was moni-
tored with a cutoff time of 3 minutes.
Phase 2: concurrent validity with the MIA model
Experimental design
In the second phase, a pilot study (n = 24 rats) was con-
ducted to test the concurrent validity of different func-
tional and neuropeptide pain assessment methods in the
MIA rat OA model. A single intra-articular injection of
MIA was performed in the right knee of 16 animals dis-
tributed among two groups (n = 8 each). An additional
sham group (n = 8) received a single intra-articular injec-
tion (50 μL) of 0.9 % NaCl. For the purpose of the study,
one of the two MIA groups also received a punctual
lidocaine (L) injection (MIA-L group) in the right knee
on days 7, 14 and 21. At the end of the 21 days of the
experimentation, all animals were euthanized with an
overdose of isoflurane and a sacrifice by transection of
the cervical spine before spinal cord collection.
Acclimatization period and baseline assessment
The study began with an acclimatization period for the
selected optimal outcomes (SWB, tactile sensitivity,
PEAP, rotarod, and treadmill), according to the optimal
acclimatization protocol of five occurrences (days -14,
-7, -5, -3, and -1) obtained in phase 1. Because of pain
induction in phase 2, tactile sensitivity could be consid-
ered as punctate tactile allodynia evaluation (PTAE).
Baseline values were acquired at day -1 in this order of
evaluation, following the above-described testing proce-
dures: SWB, PTAE, and PEAP with nociceptive stimula-
tion, rotarod and treadmill, with intra-articular injection
of MIA at day 0 in the right knee.
Intra-articular injection
On day 0, fasted (3–6 h) rats from all groups were pre-
medicated with buprenorphine hydrochloride (0.02 mg/
kg IM; Buprenex® injectable, Reckitt Benckiser Inc., Mis-
sissauga, ON, Canada) and mask-anesthetized with a
2 % isoflurane–O2 mixture. After surgical preparation, a
single intra-articular injection of 2 mg MIA (monoso-
dium iodoacetate, BioUltra®, ≥98 %, Sigma-Aldrich
Canada Co., no. I9148-5G, Oakville, ON, Canada)
dissolved in isotonic saline, or saline 0.9 % (both 50 μL
volume) was administered through the infrapatellar liga-
ment of the right knee, using a 26-gauge, 0.5-inch needle
mounted on a 0.5-mL syringe. On days 7, 14, and 21
post-MIA injection, 25 minutes before functional assess-
ment, rats from the MIA-L group were again similarly
anesthetized with a single intra-articular injection of
lidocaine through the infrapatellar ligament of the right
knee. Lidocaine Neat® (2 %, Zoetis Canada, Kirkland,
QC, Canada) was injected at a volume of 50 μL using a
26-gauge, 0.5-inch needle mounted on a 0.5-mL syringe.
Post-injection evaluation
The assessments were performed according to the spe-
cific schedules of the different groups on days 3, 7, 14,
and 21 post injection, and conducted as described for
phase 1. For the MIA-L group on days 7, 14, and 21, the
evaluation started 25 minutes after the animals recov-
ered from anesthesia. The evaluation sequence was as
follows: SWB (%BW), PTAE (grams), PEAP (percentage
of time spent on the dark side), rotarod (seconds) and
treadmill (TNTC). The schedule of evaluation was de-
signed to obtain the SWB at rest and the PTAE data be-
fore the operant testing evaluation, as this test elicits
many PWT stimulations.
Proteomic analysis
Reagents and solutions Acetic anhydride 99.5 %
(Ac2O) and ammonium bicarbonate (NH4HCO3) were
obtained from Sigma-Aldrich Inc. (St Louis, MO, USA).
SP and CGRP were purchased from Phoenix Pharma-
ceuticals Inc. (Belmont, CA, USA). Acetonitrile was pur-
chased from Thermo Fisher Scientific Inc. (NJ, USA),
and trifluoroacetic acid, formic acid and ammonium hy-
droxide 28.0–30.0 % (NH4OH) were purchased from
J.T. Baker® (Phillipsburg, NJ, USA). Standard solutions
were prepared as previously performed [54].
Instrumentation The tandem mass spectrometry
coupled to high-performance liquid chromatography
(HPLC-MS/MS) system comprises a Thermo Surveyor
autosampler, a Thermo Surveyor MS pump and a
Thermo LCQ Advantage Ion Trap Mass Spectrometer
(Thermo Fisher Scientific Inc., San Jose, CA, USA).
Data were acquired and analyzed with XcaliburTM 1.4
(Thermo Fisher Scientific Inc., San Jose, CA, USA),
and regression analysis were performed with PRISM®
(version 5.0d) (GraphPad software Inc., La Jolla, CA,
USA) using the nonlinear curve fitting module with
an estimation of the goodness of fit. The calibration
lines were constructed from the peak-area ratios of
targeted neuropeptides (SP or CGRP) and the acety-
lated SP analog internal standard.
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Bioanalytical methods Acetylated SP was used as the
internal standard. The reaction was performed as previ-
ously described [54] and the analytical method used was
also based on a previously published method [55]. The
internal standard solution was tested by HPLC-MS/MS
in multiple reactions monitoring (MRM) mode and no
residual SP were detected.
Spinal cord sample preparation At the end of the
21 days of experimentation, the entire spinal cord tissue
of rats (n = 24) was rapidly collected by a flush of saline
within the lumbar spinal canal following deep anesthesia
with isoflurane and sacrifice by transection of the cer-
vical spine. Samples were snap-frozen in liquid nitrogen
and stored at –80 °C pending analysis. Each spinal cord
was weighed accurately and homogenized using a tissue
tear or following the addition of phosphate-buffered sa-
line solution (PBS) 0.01 M at a ratio of 1:5 (v/v) and
protease inhibitor cocktail (Sigma-Aldrich Inc., Oakville,
ON, Canada, number PP8340) at the same ratio. The
samples were sonicated and the homogenate was mixed
with acetonitrile at a ratio of 1:1 (v/v) to remove larger
proteins. The samples were vortexed and centrifuged for
10 minutes (×12,000 g) and the supernatant was trans-
ferred into an injection vial then spiked with the internal
standard solution at a ratio of 1:1 (v/v). The spinal
cords from a naive group (n = 5) in phase 1 were also
collected to obtain a baseline value from normal rats
to normalize values obtained from the MIA, MIA-L,
and sham groups.
Statistical analysis
All statistical analyses were performed two-sided with an
alpha value set at 0.05 (phase 1) or 0.10 (phase 2) using
a statistical software program (SAS system for Windows,
version 9.2, Cary, NC, USA). The alpha value for phase
2 was set at 0.1 because this phase was an exploratory
study. In a pilot study, it is acceptable to set a higher
alpha value when the study has the hopes of finding an
effect that could lead to a promising scientific discovery
[56] in order to increase the power (consequently de-
creasing the risk of type II error), but increasing the
chances of type I error (i.e., saying there is a difference
when there is not). To be consistent with the statistical
rules of correction for multiple comparisons, phase 2 re-
sults were presented as adjusted p values (adj-P) because
the values obtained in the statistical report need to be
multiplied by the total number of comparisons. The nor-
mality of the outcomes was verified using the Shapiro-
Wilk test and the homogeneity of variance was assessed
using the absolute values of the residuals of the mixed
model, when appropriate.
Phase 1: reliability of pain assessment methods in normal
rats
For mechanical nociceptive thresholds and SWB, the ef-
fect of the circadian cycle was assessed using the paired
t test adapted for a crossover design. Moreover, the ef-
fect of covariates of interest, namely observer, exercise,
limb (when both left and right limbs were tested), or tri-
als (when replicates were conducted), was assessed using
a general linear model. Generalized linear mixed model
analyses for repeated measures were conducted to test
the effect of groups on TNTC and rotarod (lognormal
distribution), and PEAP (Poisson distribution). Models
accounted for baseline measurements using the baseline
as covariates. This enabled assessment of the effect of
the procedure over time using each subject as its own
control. For each model, the best structure of the covari-
ance model was assessed using information criteria that
measure the relative fit of competing covariance models.
When comparing the 5-minute periods, the Bonferroni
adjustment was applied (initial alpha value divided by 4).
Outcome repeatability (test-retest reliability) was assessed
by computing the intraclass correlation coefficient (ICC).
The ICC is a measure of the proportion of variance that is
attributable to objects of measurement. Quantifying the
test-retest reliability, the closer the ICC is to 1.0, the higher
the reliability and the lower the error variance [57]. A ratio
of 0.3–0.4 indicates fair agreement, 0.5–0.6 moderate
agreement, 0.7–0.8 strong agreement, and >0.8 almost per-
fect agreement. Moreover, the coefficient of variation (CV),
as a normalized measure of dispersion of the distribution,
was used to test the effect of the proposed acclimatization
protocols. The CV for each variable was calculated at day
-14 (initial assessment), and the variation in CV was
assessed at the end of each acclimatization protocol as the
CV ratio of day -1 (final assessment) to day -14. At the ini-
tial assessment (day -14), the CV interpretation was as fol-
lows: <10 % indicated almost perfect dispersion, 11–25 %
light dispersion, and 26–40 % fair dispersion. The day -1/
day -14 CV ratio indicated improvement (decrease in vari-
ability) related to the acclimatization protocol if it was <1,
and deterioration (increase in variability) if >1.
Phase 2: concurrent validity with the MIA model
The SWB and PTAE data were expressed as the average
obtained from the three trials on the RHP. Data were
then analyzed using linear mixed models (SWB and
PTAE) or generalized linear mixed models for repeated
measures. Treatment groups and day were considered as
fixed effects and animals in groups as random effects.
Models accounted for baseline measurement using the
baseline as a covariate. For each model, the best struc-
ture of the covariance model was assessed using a graph-
ical method (plots of covariance versus lag in time
between pairs of observations compared to different
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covariance models), and using information criteria that
measure the relative fit of competing covariance models.
When multiple comparisons were carried out, the
Tukey-Kramer adjustment was used to obtain adj-P
values. Neuropeptide data were analyzed using the un-
paired exact Wilcoxon test with an alpha value set at
0.10 following non-parametric Kruskal-Wallis one-way
analysis of variance.
Results
Phase 1: reliability of pain assessment methods in normal
rats
Data variability and influence of environment
The repeatability of measurements made with different
assessment methods was tested in normal rats, and the
influence of environment, including observer, inverted
circadian cycle (activity during the day), exercise, limb,
and trial, was assessed on testing.
Mechanical sensitivity We did not find any effect of
observer, circadian cycle, exercise, or limb in the PWT
measured with the Randall Selitto test Paw Pressure
Meter®. However, the data obtained with this test were
highly variable among individuals and not repeatable
(ICC <0.3).
Tactile sensitivity The PWT measured with the Elec-
tronic von Frey Anesthesiometer® in normal rats gave
average values of 40–80 g in both hind limbs. The obser-
ver, the circadian cycle, and exercise did not produce
any effect on tactile sensitivity. No significant difference
between the right and left hind limbs, or trial effect (in
the triplicates) was observed. However, the data were
markedly variable over the whole period (6 days in total)
with an ICC for both hind limbs <0.5. Following repeti-
tion of the experiment in five rats over 25 days, the ICC
improved after excluding the first 2 weeks of daily evalu-
ation. More precisely, the ICC for days 15, 18, and 25
was >0.8 for both hind limbs (Table 1).
Static weight bearing In normal animals, the Incapaci-
tance Meter® apparatus measured average values of
weight distributed over each hind limb between 35 and
38 % BW. The observer, the circadian cycle, and exercise
did not produce any effect on SWB. No significant dif-
ference between the right and left hind limbs, or trial ef-
fect (in the triplicates) was observed. When analyzing
the last two days of assessment (in comparison to the
whole period of 6 days), the ICC improved (Table 2),
and this was particularly evident for the SWB ICC after
exercise (ICC >0.7 in both hind limbs for the last 2 days
of assessment). This suggests that the treadmill exercise
slightly decreased the inter-individual variability in SWB
measurement. Finally, following repetition of evaluation
over 15 days with in four rats, the ICC improved after
excluding the first week of daily evaluation (days 1 to 5),
with a value ≥0.66 for days 8 and 15 in both hind limbs
(Table 2).
Treadmill The treadmill exercise sessions were gener-
ally well accepted by female Sprague-Dawley rats (84 %
acceptability). Neither the observer, nor the circadian
cycle produced any effect on the TNTC. The TNTC was
extremely repeatable with an ICC of 0.84. A period ef-
fect was demonstrated (P = 0.003) in the 15-day study in
four rats (Fig. 1). Post hoc analysis showed that the ini-
tial and final 5-minute periods were different for TNTC
(P = 0.0002), whereas both intermediate 5-minute pe-
riods (numbers 2 and 3) were highly repeatable with an
ICC of 0.73 and 0.92, respectively.
Place escape/avoidance paradigm The first experiment
with operant testing was done without nociceptive
stimulus. Neither the observer, nor the circadian cycle
produced any effect on the preferential localization. The
localization was highly repeatable among animals, with
an ICC of 0.90, where the rats spent 91 % of their time
on the black side. A period effect was demonstrated (P
< 0.0001) in the 25-day study of five rats (Fig. 2). The
PEAP assessment with nociceptive stimulation once
again demonstrated robust repeatability, with an ICC
of 0.83, and rats spent 81 % of their time on the black
side. The post hoc analysis showed that the intermedi-
ate 5-minute periods (numbers 2 and 3) were similar
in the percentage of time, and were highly repeatable
Table 1 Test-retest reliability of the tactile sensitivity evaluation
LHP RHP
ICC over the whole period 0.78 0.26
ICC for days 7, 15, 18, and 25 0.79 0.27
ICC for days 15, 18, and 25 0.84 0.81
A group of normal rats (n = 5) was tested with the Electronic von Frey
Anesthesiometer® daily from days 1 to 15 and then on days 18 and 25. The
intraclass correlation coefficients (ICCs) for values calculated for the entire
evaluation period were compared to values calculated after exclusion of the
first week and the first two weeks of assessment. LHP left hind paw, RHP right
hind paw
Table 2 Test-retest reliability of the static weight bearing
Before exercise After exercise
LHP RHP LHP RHP
ICC over the whole period 0.00 0.00 0.00 0.23
ICC for days 8 and 15 0.67 0.66 0.66 0.76
A group of normal rats (n = 4) was tested for static weight bearing before and
after treadmill exercise daily from days 1 to 5 and then on days 8 and 15. The
intraclass correlation coefficients (ICCs) calculated for the entire evaluation
period were compared to ICCs calculated after exclusion of the first week of
assessment. LHP left hind paw, RHP right hind paw
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and different (P ≤ 0.0216) from the initial and final 5-
minute periods.
Rotarod Neither the observer, nor the circadian cycle
produced any effect on the performance time in the
rotarod, and this performance time was highly repeat-
able with an ICC of 0.92.
Influence of acclimatization protocols and comparison of
assessment method variability
When looking at the different assessment methods for the
initial day of acclimatization (day -14), inter-individual
variability (CV) appeared lower for the SWB, followed by
PEAP, tactile sensitivity, and treadmill (TNTC) evaluation,
with mechanical sensitivity last (Table 3). The variation
in CV at day -1, normalized to day -14, as tested by the
day -1/day -14 CV ratio, was compared between
acclimatization protocols for the different pain assess-
ment methods (Table 3). The most intensive protocol
with the highest number of acclimatization procedures
(n = 8) presented the lowest variability between days -1
and -14, similar to the protocol with 6 or 5 days of
acclimatization. The protocol with only 4 days of
acclimatization yielded the highest variations in CV.
The acclimatization protocol using five occurrences of
exposition to different assessment methods appeared
the most appropriate to limit variability in assessment.
Phase 2: concurrent validity with the MIA model
The MIA injection successfully induced pain-related
changes as assessed by SWB, PTAE, PEAP, and TNTC.
However, the rotarod was not sensitive to MIA-induced
pain, as all groups had similar (maximal) time of accept-
ance. In consequence, no further analysis was conducted
with this testing modality. The sham injection was not
totally neutral when compared to baseline values: while
no effect was present for SWB or TNTC, the sham
group had a transient decrease in PTAE (days 7 and 14)
and PEAP (days 3 and 7). The response to lidocaine in-
jection varied by assessment method: a clear analgesic
effect was noted with PTAE (on days 7 and 14), and
PEAP (on days 7, 14 and 21); a trend toward better per-
formance was observed with TNTC, but no difference
was observed with MIA for SWB. Neuropeptide spinal
quantification permitted validation of the lidocaine treat-
ment effect and the pain generated by MIA injection.
Static weight bearing
Analysis of SWB data demonstrated a group effect (P =
0.0005), a time effect (P < 0.0001) and a time x group ef-
fect (P = 0.005). In the MIA group, the nadir of weight
force was observed on day 3 and was different from
values recorded on days 7 (adj-P = 0.005), 14 (adj-P =
0.01) and 21 (adj-P = 0.001) (Fig. 3). No significant differ-
ence within time was observed for the sham group,
whereas in the MIA-L group, day 3 RHP SWB (without
lidocaine injection) was lower than on day 14 (adj-P =
0.001). Compared to the sham group, the RHP SWB de-
creased on day 3 in the MIA (adj-P = 0.002) and the
MIA-L (adj-P = 0.001) groups. Subsequently, the RHP
SWB in the MIA group returned to levels similar to
Fig. 1 Treadmill exercise repeatability (least squares mean ± standard
error of the mean). A group of four animals was tested on the treadmill,
recording the number of total crossings over 20 minutes (period 1 =
0–5 minutes, period 2 = 5–10 minutes, period 3 = 10–15 minutes, and
period 4 = 15–20 minutes), daily from days 1 to 5, and then on days 8
and 15. The treadmill numbers of total crossings were transformed to
fit a lognormal distribution. a,b,c Statistically significantly different
inter-period statistical differences (adjusted P value = 0.002
Fig. 2 Place escape/avoidance paradigm operant test repeatability
(least squares mean ± standard error of the mean). A group of five
animals underwent the place escape/avoidance parading operant
test (percentage of the time spent on the dark side) over a 20-minute
(period 1 = 0–5 minutes, period 2 = 5–10 minutes, period 3 = 10–15
minutes, and period 4 = 15–20 minutes) daily from days 1 to 15, and
then on days 18 and 25. a,b,c Significant inter-period differences
(adjusted P value ≤0.0216)
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those in the sham group, and at no time point of evalu-
ation did the lidocaine injection provide any benefit.
Punctate tactile allodynia evaluation
Descriptive statistics for the RHP PTAE over the evalu-
ation days are provided in Table 4. The PWT was lower
after the MIA injection on days 3, 7, 14, and 21. This was
also the case for the sham group on days 7 and 14. In the
MIA-L group, the nadir in PWT was observed on day 3,
whereas a significant increase was observed on days 7 and
14. There was a difference between MIA and MIA-L on
days 7 (adj-P = 0.07) and 14 (adj-P = 0.08) (Fig. 4).
Place escape/avoidance paradigm
Between-group analysis confirmed a significant treat-
ment effect of lidocaine, in which MIA-L was different
from MIA (P = 0.07) and different from sham (P = 0.01)
(Fig. 5). The group difference was particularly present
for the two intermediate periods 2 and 3 of PEAP as-
sessment previously observed as the most repeatable
ones (see “Phase 1”).
Treadmill
There was close similarity in the type of performance on
the treadmill in the MIA-L and sham groups, in which
their TNTC remained comparable to baseline values. In-
versely, the TNTC in the MIA group decreased from
day 7 onward. However, the observed between-group
difference was not significant (P = 0.14).
Neuropeptides
The mean relative ratio (RR) of neuropeptide concentra-
tions of SP and CGRP 21 days after induction of OA are
shown in Fig. 6. The absolute values of the concentra-
tion of neuropeptides have all been normalized to the
function of the naive group values and are shown as the
RR. Compared to the naive group (Table 5 and Fig. 6)
with a RR of 1, the SP concentrations were significantly
increased in the MIA model (adj-P = 0.016) with 2 mg of
MIA (RR 1.77 ± 0.16) as in the lidocaine treatment group
(MIA-L) (RR 1.43 ± 0.09). The level of this peptide was
statistically higher in the MIA group (adj-P = 0.029)
compared to the sham group injected with saline 0.9 %
(RR 1.26 ± 0.14). However, both the sham and MIA-L
groups have significantly lower SP concentrations when
compared to the MIA group (adj-P = 0.029). The con-
centration of CGRP was significantly increased in both
MIA models (RR 2.29 ± 0.39 and 2.09 ± 0.29 for MIA
and MIA-L, respectively). The sham group (RR 1.22 ±
0.07) had an increase too, in comparison with the naive
group (adj-P = 0.016). On the other hand, both MIA
groups had a statistically significantly higher level of
CGRP than the sham group (adj-P = 0.029). When com-
pared to the MIA group, the MIA-L group had a statisti-
cally similar level of CGRP neuropeptide (adj-P = 0.200).
Table 3 Coefficient of variation (CV) for each outcome and variation in CV between four protocols of acclimatization
8 Days 6 Days 5 Days 4 Days
Functional evaluationa CV (D-14) CV* ratio CV (D-14) CV* ratio CV (D-14) CV* ratio CV (D-14) CV* ratio
SWB 17.3 0.72 31.2 0.30 11.7 0.62 12.2 0.67
PEAP 23.8 1.01 24.1 1.07 21.3 0.97 22.8 1.11
TS 42.9 0.85 22.9 1.24 20.4 1.01 27.4 1.80
TNTC 36.9 1.10 106.5 0.54 31.2 0.91 38.0 1.92
MS 63.3 0.74 71.8 1.07 72.2 0.71 75.3 0.53
aThe functional evaluation includes the values recorded for the right hind limb, when available (static weight bearing (SWB), tactile sensitivity (TS), mechanical
sensitivity (MS)), or the response of the animal (place escape/avoidance paradigm (PEAP) and treadmill number of total crossings (TNTC)). *The CV values calculated on
day -1 were normalized to the CV values on day -14 (D-14) to test the influence of the acclimatization protocol on the outcome measures. A day -1/day -14 CV ratio
value <1 was indicative of improvement in variability and is presented in bold italics
Fig. 3 Static weight-bearing (SWB) evolution after induction of
osteoarthritis (least squares mean ± standard error of the mean). On
day 3, the monosodium iodoacetate (MIA) intra-articular injection in
the right knee induced asymmetrical weight distribution in the rats
injected with MIA (adjusted P value (adj-P) = 0.0024) and rats injected
with MIA and punctual lidocaine (MIA-L) (adj-P = 0.0011) compared to
rats injected with 0.9 % saline (sham). Subsequently, a statistically
significant difference in right hind paw SWB was only observed between
the sham and MIA-L groups at days 7 and 21. %BW percentage of body
weight. a,bSignificant inter-group statistical differences
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Discussion
Rat models are common in OA research as they are easy
to customize and are cost-effective [58]. The MIA model
in particular can be standardized and is associated with
rapidly developing well-characterized lesions [23, 30]. In
an effort to improve the translation of preclinical OA re-
search to the clinical field, we conducted a two-phase
study, first, to determine the most reliable pain assess-
ment method protocol, and second, to validate this
protocol in the most common chemical model of OA in
rats with concomitant changes in spinal neuropeptide
concentrations.
Initially, the effect of the environment (inverted circa-
dian cycle, activity level (treadmill exercise), and obser-
ver) was tested using well-known pain assessment tools.
Prior studies have demonstrated an effect of the inverted
circadian cycle on pain research protocols with rodents
[59–61]. Our results did not suggest any impact of con-
ducting the evaluation during daytime (more convenient
for the investigator). Our group reported a significant
reduction in variability of kinetics measures after exer-
cise in cats [62] and dogs [63] with OA. The current
study confirmed beneficial effects of exercise to reduce
SWB (or other outcome) variability in the MIA rat
model of OA. This study also qualified TNTC as a quan-
titative pain measure using spontaneous behavior. Im-
portantly, the study tested reliability and validity of
TNTC, and the potential impact on results obtained
with other pain assessment methods, which may be used
concurrently. Our results confirmed that a broad range
of methods can be combined for pain assessment in the
same animals while maintaining reliability and scientific
validity.
Finally, as different observers can introduce some de-
gree of bias in pain assessment outcomes, inter-rater re-
liability was tested by observers with different levels of
expertise (one intermediate and one advanced). The
methodology included in the current study was access-
ible to an observer with intermediate experience, as no
significant difference was identified during analysis based
on the level of experience. As a limitation, the number
of observers was minimal, as both observers were
women, and only objective assessment methods were se-
lected for this study (limiting any bias related to subject-
ive observation). Therefore, such a hypothesis (the
potential influence of experience, and/or gender) would
need to be tested further before making inferences from
the results. This is particularly important, as recent work
has established the influence of the observer’s gender in
inducing stress-related analgesia in rodents [64]. Simi-
larly, for limiting the influence of interferential factors in
studying the effect of environment, only female rats were
used. A possible gender effect would need to be tested
in future experiments. Indeed, male rodents are recog-
nized as more sensitive to olfactory exposure to males,
including men, causing stress and related analgesia [64].
Moreover, sexual dimorphism [65] and hormonal influ-
ence [66, 67] have been observed in endogenous pain
modulation mechanisms. Finally, women are more rep-
resented in the field of chronic pain [68]; however, many
reasons have been explored to investigate this finding
[69]. Also, for decades, males have been overrepresented




-1 3 7 14 21
Mean SD Mean SD Mean SD Mean SD Mean SD
MIA 53.8 11.2 39.2 13.1 43.1 13.7 40.0 10.0 39.8 8.5
MIA-L 70.4 16.8 35.0 13.8 52.6 12.7 47.8 14.3 36.2 17.8
Sham 56.3 16.9 49.0 14.8 39.2 16.6 37.0 17.6 45.6 17.0
Descriptive statistics of the punctate tactile allodynia evaluation (PTAE) of the right hind paw. The measure was obtained for the three groups (eight animals per
group) in grams on days 3, 7, 14, and 21 following the intra-articular injection of monosodium iodoacetate (MIA). Intra-articular injection was performed on day 0
(2 mg of MIA for the MIA and rats injected with monosodium iodoacetate and punctual lidocaine (MIA-L) groups and 0.9 % NaCl for the sham group). The MIA-L
group also received an intra-articular injection of lidocaine in the right knee on days 7, 14, and 21, at 25 minutes before the PTAE. SD standard deviation
Fig. 4 Right hind paw (RHP) withdrawal threshold evolution after
induction of osteoarthritis (least squares mean ± standard error of
the mean). On days 7 (adjusted P value (adj-P) = 0.07) and 14 (adj-P =
0.08), the RHP paw withdrawal threshold was increased for the rats
injected with monosodium iodoacetate and punctual lidocaine (MIA-L)
when compared with rats injected with MIA
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in preclinical research. This situation can definitely lead
to a certain bias [70]. All these previous studies justify
our decision to use female rats.
As a recognized indicator of test-retest reliability [57],
the ICC demonstrated that assessment of mechanical
sensitivity using the Randall Selitto test presents poor re-
peatability, and this outcome cannot be recommended
for a valid reflexive measure of pain. The phase 1
experiments demonstrated that SWB and tactile sensitiv-
ity can produce more repeatable data when animals (and
the observer) are allowed to acclimate to the test device
for at least one week. Similarly, there was a slight reduc-
tion in the variability of SWB when measured after
treadmill exercise. However, the beneficial effects of ex-
ercise were not as significant in the chemically induced
OA rat model as those observed in cats with naturally
Fig. 5 Place escape/avoidance paradigm (PEAP) evolution after osteoarthritis induction (least squares mean ± standard error of the mean). The
percentage of time spent on the PEAP dark side was statistically higher in the lidocaine-treated rats with monosodium iodoacetate (MIA-L) when
compared to the rats injected with monosodium iodoacetate (MIA) (P = 0.07) and the sham group (P = 0.01) group. Data presented here were
collected for the whole period of assessment (20 minutes) at each day, but the observed between-group differences were the most obvious
during the intermediate periods 2 (5–10 minutes) and 3 (10–15 minutes)
Fig. 6 Spinal substance P (SP) and calcitonin gene-related peptide (CGRP) concentrations 21 days after monosodium iodoacetate (MIA) injection
(relative ratio (RR) mean and SD). Mean RR spinal cord concentration was normalized to the naive group. An RR of 1 indicated the concentration
of normal rats from the naive group. The RR for SP and CGRP were increased in all groups (including the sham group) but had a higher peak after
MIA injection. Lidocaine treatment (L) induced a lesser liberation of SP and CGRP (albeit not statistically significant for the latter) in the spinal cord
of the MIA-L group. a,b,cSignificant inter-group statistical differences (adjusted P value <0.10)
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occurring OA [62, 71]. The PEAP, rotarod, and treadmill
activity measured as TNTC appeared to be highly re-
peatable without requiring prolonged acclimatization. It
must be noted that in both treadmill and PEAP, the
intermediate periods 2 and 3 (i.e., 5–10 minutes, and
10–15 minutes, respectively) demonstrated the highest
repeatability. These results also suggest that the tread-
mill and PEAP sessions are a little too long, so for future
experimentation the session could be reduced in both
cases to 15 minutes instead of 20 minutes. To our know-
ledge, this study is the first to evaluate the test-retest (re-
peatability) and inter-rater (reproducibility) reliability of
a complete set of pain assessment methods in normal
rodents.
As a measure of distribution dispersion that does not
require similar units and therefore allows comparison of
different variables, the CV of each pain assessment
method was verified. At the first evaluation, we again
observed the poor metrological property of mechanical
sensitivity, presenting the highest inter-individual vari-
ability (around 70 % CV). Moreover, the different
acclimatization protocols did not help to decrease this
variability as the variation in CV from the last to the first
evaluation was between 0.53 and 1.07. On the other side,
our results support the importance of choosing the opti-
mal acclimatization protocol for pain assessment in the
rat model. To our knowledge, this study represents the
first systematic evaluation of the effect on data variability
of different acclimatization protocols, including four to
eight assessments over a 2-week period, with a series of
tests near or far from the others. The most reliable
acclimatization protocol included five assessments with
exposure to the testing methods every other day for the
last week (days -14, -7, -5, -3, and -1), with baseline
values acquired at day -1.
The second exploratory phase of our project evaluated
the validity of the most promising pain assessment
methods as determined during phase 1, when applied to
the MIA model of OA in rats. Briefly, SWB, PTAE,
PEAP, and TNTC detected pain-related changes follow-
ing OA induction with an intra-articular MIA injection
and were validated by increased release of spinal
neuropeptides such as SP and CGRP. However, the
rotarod assessment, as used in our experimental condi-
tions, was not sensitive to induction of OA pain. More-
over, the PTAE and PEAP methods demonstrated that
the sham injection of 0.9 % NaCl was not totally neutral,
which was confirmed by the augmentation of spinal lib-
eration of SP (26 times higher) and CGRP (22 times
higher) in the sham group. Interestingly, PTAE and
PEAP also confirmed the analgesic effect of intra-
articular lidocaine injection by the downregulation of
spinal neuropeptides, whereas TNTC and SWB did not
detect the expected analgesic effect. These results sug-
gest that SWB detects more biomechanical alterations of
the joint than ongoing pain and consequently, could be
a sensitive method to detect knee joint dysfunction. Of
the four pain assessment methods evaluated for concur-
rent validity, only PEAP detected a treatment effect of
lidocaine with a significant difference between the MIA-
L group and both the sham and MIA groups. Interest-
ingly, body weight was not affected, either by possible
manipulation-related stress in phase 1, or by MIA in-
duction of pain in phase 2. This confirms the possible
lack of sensitivity of different endpoints used in re-
search, such as feeding, drinking, etc., for determining
quality of life.
The enhanced escape/avoidance behavior and lower
PWT were previously demonstrated in both neuropathic
and inflammatory pain models [33, 41, 47, 72, 73]. The
higher sensitivity of PEAP compared to PTAE in detect-
ing the efficacy of pain relief was also demonstrated in
other studies [33].
It would be logical to consider that animals would al-
locate roughly a similar amount of time in both environ-
ments if they do not show natural preference or aversion
to one of the two environments in the PEAP testing.
This study clearly establishes a strong preference of the
rat, a nocturnal animal, to the dark side of the test ap-
paratus. The acclimatization of rats to the test apparatus
is fast, the establishment of a baseline is preferable, and
both intermediate periods 2 and 3 are highly repeatable.
Moreover, PEAP assessment includes both classical (Pav-
lovian) and operant conditioning in the process of train-
ing [42]. When compared with PEAP, PTAE required a
longer acclimatization period for both the animal and
the observer (at least one week as demonstrated in this
study). However, assessing the escape/avoidance behav-
ior using the PEAP required a much longer evaluation
time (with 20 to 30 minutes required for each animal),
being too labor-intensive to the experimenters, while
no automated apparatus is commercially available for
this test.
Interestingly, the intra-articular lidocaine injection af-
fected both PTAE and PEAP, and to a lesser degree
TNTC, but did not alter changes in weight bearing on
Table 5 Neuropeptides inter-group comparisons in the
monosodium iodoacetate osteoarthritis rat model
Inter-group comparisons SP CGRP
Three groups vs. naive rats 0.016* 0.016*
MIA vs. sham 0.029* 0.029*
MIA-L vs. sham 0.057* 0.029*
MIA-L vs. MIA 0.029* 0.200
MIA monosodium iodoacetate, MIA-L rats injected with monosodium iodoacetate
and treated with punctual lidocaine injection, SP substance P, CGRP calcitonin
gene related-peptide. *Inter-group statistically significant difference (adjusted
P value)
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the RHP. The lack of effect of lidocaine on SWB could
be related to reduced pain in the absence of movement
in this model. In a recent study [25], intra-articular lido-
caine (200 μL) was efficient to reduce the shift in weight
bearing at day 14 post-MIA injection, but only for the
highest dose of MIA (4.8 mg). The lower MIA dose and
volume in our study (2 mg and 50 μL) combined with
the lower sensitivity of SWB may be responsible for the
lack of effect with this method, while PEAP and PTAE
accurately captured the expected pharmacological effects
of lidocaine. Intra-articular lidocaine was chosen for the
analgesic test in this study, because of the apparently
controversial results obtained in conditioning proce-
dures with non-steroidal anti-inflammatory and opioid
drugs (for review, see [42]).
These findings may be useful when designing studies
of the efficacy of analgesia using the MIA-induced OA
rat model. Moreover, there is also some evidence that
the combination of the quick-acting effect of lidocaine
(reaching a peak effect at 10 minutes after the intra-
articular injection on a CatWalk) [74] and the necessary
time to induce a change in the distribution of gait in
supraspinal locomotor areas in patients with OA [75],
seems to explain the lack of detection of lidocaine anal-
gesia by SWB. Previous studies combined with our re-
sults, provide evidence for future use of a continuous
infusion of lidocaine to obtain a more sustained anal-
gesic effect, attaining higher lidocaine synovial levels for
a prolonged time period.
The intra-articular injection of saline (sham group)
generated some hyperalgesia or allodynia, as assessed by
PTAE and reflected by the observed change in the oper-
ant testing. This is supported by the recent finding of
some increased NF-kB activity on days 3 and 7 mea-
sured by in vivo luminescent imaging in a transgenic
mouse model receiving an intra-articular injection of sa-
line [76]. Moreover, in the MIA mouse model tested in
the same study, temporal kinetics of NF-kB activity were
strongly correlated with mechanical allodynia (PTAE)
and serum interleukin (IL)-6 levels in the inflammatory
phase (day 3) of this model, while serum IL-1β was
strongly correlated with pain sensitivity in the chronic
pain phase (up to day 28) [76]. An increase in the intra-
articular pressure and possible injection-related inflamma-
tion are proposed to explain this finding. Based on these
results, a neutral control group (without intra-articular in-
jection) may be valuable in future experiments.
The MIA model is recognized as valuable in OA re-
search for its ability to detect analgesic effects of different
drugs and compounds. The initial inflammatory phase of
this model allows the evaluation of various non-steroidal
anti-inflammatory drugs and cyclo-oxygenase inhibitors
[14, 24, 27, 77]. Moreover, the efficacy of morphine, gaba-
pentin, pregabalin, and the transient receptor potential
vanilloid receptor antagonist was successfully demon-
strated in this model [15–17, 24, 77]. Moreover, some
studies showed that MIA-induced OA leads to an increase
in the neuron firing rate and a reduced activation thresh-
old of the afferent nerve fibers [78], which consequently
leads to sensitization of spinal neurons in the dorsal
horn [79]. In this study, spinal cord neuropeptide quan-
tification suggests and supports development of central
sensitization in this model. Indeed, our study confirms
an increase in spinal biomarkers of SP and CGRP, as
previously observed in the MIA model [51].
The upregulation of spinal neuropeptides observed in
this study suggests activation of the peptidergic afferent
C-fibers, resulting in central sensitization. It has been
well-demonstrated [80], by relative increasing expression
of target gene mRNA like pro-inflammatory cytokines
(IL-1 and tumor necrosis factor) and pain mediators
(CGRP, SP, neuropeptide Y, and galanin), that MIA-
induced joint degeneration in rats generates an animal
model suitable for mechanistic and pharmacologic
studies on nociceptive pain pathways caused by OA.
Altogether, this provides further key in vivo evidence
that OA pain could be caused by central sensitization
through communication between peripheral OA noci-
ceptors and the central sensory system [81, 82]. Despite
the fact that SWB did not detect lidocaine treatment on
day 21, or asymmetry of weight distribution, our study
clearly demonstrated that lidocaine analgesic effects noted
by PEAP were translated by concomitant significant down-
regulation of spinal SP, which was 34 times lower, and of
CGRP, which was 20 times lower on day 21.
These results mimic similar therapeutic effects on be-
havior and SP and CGRP spinal cord expression of intra-
articular resiniferatoxin [83] and proteasome inhibitor
MG132 [84] in the MIA OA pain model in rats. Unfortu-
nately, we observed that the MIA model caused temporary
changes of short duration (return to baseline values at day
21 post injection) and relies on a disease mechanism
(chemical inhibition of glyceraldehyde-3-phosphate de-
hydrogenase activity in chondrocytes, resulting in cell
death following the disruption of its cellular glycolysis
process [15, 16, 18]) that differs from human natural OA,
which could limit the predictability of the therapeutic ef-
fect of analgesic and disease-modifying agents. Finally,
higher levels of spinal neuropeptides at sacrifice clearly
confirms that our model caused some long-term pain or
OA damage.
Conclusion
Pain assessment methods used with the MIA model
should be selected and scheduled appropriately. In this
study only mechanical sensitivity had poor metrological
properties, but SWB, the operant PEAP testing, tactile
sensitivity, rotarod, and treadmill (TNTC) were repeatable
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under different environmental conditions. The rotarod
test did not achieve sufficient sensitivity to detect OA pain
induced by MIA injection in rats and may not be included
in future studies. For detecting the analgesic effect of local
administration of lidocaine, the pain assessment method
that demonstrated the best results was the operant testing,
which had the greatest sensitivity, followed by PTAE,
whereas SWB had some limitation in sensitivity. Spinal
neuropeptide quantification at the end of the experiment
has allowed us to validate the effect of positive lidocaine
treatment in a more objective manner, as MIA can induce
pain. However, the main limitation of this study was the
small sample size. Furthermore, it was possible to increase
the validity and reliability of pain assessment methods
with an optimal acclimatization protocol (five assessments
over 2 weeks). In addition, the sham intra-articular saline
injection was not totally neutral, particularly with more
sensitive methods such as PEAP, PTAE, and this was
confirmed by the release of spinal neuropeptides. We
therefore recommend the addition of a naive control
group (without intra-articular injection). Moreover, in-
creased neuropeptide levels obviously support the cen-
tral sensitization observed in the MIA rat model. The
present results highlight potential for these neuro-
mediators as pharmacological biomarkers for analgesic
testing in association with sensitive functional assess-
ment methods.
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